Free press releases distribution network?

Agency / Source: Visiongain

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



World Biosimilars Market to Reach $1.6 Billion in 2012 According to New Visiongain Report - A new report by visiongain, a London-based business information company, predicts that global revenues for biosimilars will reach $1.6 billion in 2012
World Biosimilars Market to Reach $1.6 Billion in 2012 According to New Visiongain Report

 

PRZOOM - /newswire/ - London, United Kingdom, 2012/04/10 - A new report by visiongain, a London-based business information company, predicts that global revenues for biosimilars will reach $1.6 billion in 2012.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Visiongain forecasts that monoclonal antibodies will become the largest sector of the biosimilars market by 2022. Biosimilar monoclonal antibodies will reach developed markets, such as the US and the EU, by the middle of the decade, with Roche’s Rituxan likely to be the first target. By 2016, revenues for the segment will reach $849m. By then, however, biosimilar insulin and insulin analogues will be the largest sector of the market, having grown since 2011 with a CAGR of 41.4%.

Richard Lang, a pharmaceutical industry analyst at visiongain, said: “Biosimilars are an exciting opportunity for companies seeking to enter or maintain a presence in the biopharmaceutical industry. Sandoz and Teva are the major players in developed markets currently, although their position will be challenged in the near future by many other generics and Big Pharma companies. Merck & Co.’s potential $720m deal with Hanwha Chemical shows the level of money companies are willing to invest in this fast-growing market.”

This study forecasts revenues of six leading segments of the biosimilar market. In 2011, erythropoietins, G-CSF and growth hormones accounted for 42.1%. Products from these sectors are available in most major developed and emerging markets, although uptake is varied for each class. Sandoz’ Omnitrope (somatropin), for example, accounts for less than 5% of the US growth hormones market.

The new report also discusses leading national markets for biosimilars. In 2011, China was the largest national market, although with around 150 players, the market there is fragmented. The US market will remain small in 2012, as patents continue to cover many leading biologics. However, the release of draft development guidelines by the FDA in February 2012, as well as patent expiries from 2014 onwards, will cause strong growth towards the middle of the decade. By 2022, the US will be the world’s second largest market for biosimilars.

Rising incidence of diseases, cost restrictions by healthcare payers and biologic patent expiries will all act as growth drivers for this rapidly expanding industry and market. Increasing interest from leading pharmaceutical companies, multinational generics manufacturers and biotechnology companies will give strong growth for the world biosimilar market from 2012 onwards. Biosimilars and Follow-On Biologics: World Market 2012-2022 adds to visiongain’s range of analytical research reports on the biopharmaceutical industry.

For sample pages and further information concerning the visiongain report the Biosimilars and Follow-On Biologics: World Market 2012-2022 please visit the website.

About visiongain
Visiongain (visiongain.com) is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Visiongain

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


World Biosimilars Market to Reach $1.6 Billion in 2012 According to New Visiongain Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Sara Peerun - Visiongain.com 
+44(0)20 7336 6100 sara.peerun[.]visiongainglobal.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Visiongain securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Visiongain / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  SKS Media | SKS Associates Ltd

Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today